Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Novocure Gmbh

Clinical trials sponsored by Novocure Gmbh, explained in plain language.

NovoCure GmbH NVCR NASDAQ

A medical device company developing tumor-treating electric fields for cancer therapy.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 2 Terminated 1

Electric field therapy plus immunotherapy tested for tough lung cancers

Disease control Terminated

This study tested a wearable device that sends low-intensity electric fields to tumors, combined with the immunotherapy drug pembrolizumab, in people with advanced non-small cell lung cancer that had already been treated with chemotherapy and immunotherapy. The goal was to see if…

Phase: PHASE2 • Sponsor: NovoCure GmbH • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC